A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab among Healthy Chinese Male Subjects.
Frontiers in Pharmacology（2021）
关键词
adalimumab,biosimilar,immunogenicity,pharmacokinetics,intersubject variability
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要